Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation
about
Immunotherapy for head and neck cancer: latest developments and clinical potentialManagement of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelinesNovel immunotherapies in lymphoid malignanciesAdoptive T-Cell ImmunotherapyLymphoma Immunotherapy: Current StatusAdoptive immunotherapy for acute leukemia: New insights in chimeric antigen receptorsEffects of T-Cell Depletion on Allogeneic Hematopoietic Stem Cell Transplantation Outcomes in AML PatientsPreventing stem cell transplantation-associated viral infections using T-cell therapyCord blood graft engineeringEpstein Barr virus-associated lymphoproliferative diseases: the virus as a therapeutic targetT lymphocytes targeting native receptorsEpstein-Barr virus lymphoproliferative disease after hematopoietic stem cell transplantPosttransplant lymphoproliferative disease after pediatric solid organ transplantationAntiviral T-cell therapyAdoptive cell therapies for glioblastomaTherapeutic bispecific T-cell engager antibody targeting the intracellular oncoprotein WT1.Adoptive transfer of EBV specific CD8+ T cell clones can transiently control EBV infection in humanized miceRecent Developments in Cellular Immunotherapy for HSCT-Associated ComplicationsManufacture of tumor- and virus-specific T lymphocytes for adoptive cell therapiesCharacterization of a c-Rel Inhibitor That Mediates Anticancer Properties in Hematologic Malignancies by Blocking NF-κB-Controlled Oxidative Stress ResponsesAdoptive immunotherapy for primary immunodeficiency disorders with virus-specific T lymphocytesHeterogeneity in clinical course of EBV-associated lymphoproliferative disorder after allogeneic stem cell transplantation.Establishment and operation of a Good Manufacturing Practice-compliant allogeneic Epstein-Barr virus (EBV)-specific cytotoxic cell bank for the treatment of EBV-associated lymphoproliferative disease.A small-molecule c-Rel inhibitor reduces alloactivation of T cells without compromising antitumor activityToward a Rapid Production of Multivirus-Specific T Cells Targeting BKV, Adenovirus, CMV, and EBV from Umbilical Cord Blood.Engineering cord blood to improve engraftment after cord blood transplant.Controlling cytomegalovirus: helping the immune system take the leadActivity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT.Generation of tumor-targeted human T lymphocytes from induced pluripotent stem cells for cancer therapy.Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins.Children's Oncology Group's 2013 blueprint for research: non-Hodgkin lymphoma.Rapid generation of clinical-grade antiviral T cells: selection of suitable T-cell donors and GMP-compliant manufacturing of antiviral T cells.Lymph Node Flow Cytometry as a Prompt Recognition of Ultra Early Onset PTLD: A Successful Case of Rituximab Treatment.The coming of age of adoptive T-cell therapy for viral infection after stem cell transplantation.Graft versus leukemia response without graft-versus-host disease elicited by adoptively transferred multivirus-specific T-cells.Blood and marrow transplant clinical trials network state of the Science Symposium 2014Immunotherapy with Donor T Cells Sensitized with Overlapping Pentadecapeptides for Treatment of Persistent Cytomegalovirus Infection or Viremia.T-cell therapy for viral infections following transplantation: why stop at three viruses?Enhanced antitumor effect of combining chemotherapy with Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes in mice with EBV-related non-Hodgkin's lymphoma.Moving Successful Virus-specific T-cell Therapy for Hematopoietic Stem Cell Recipients to Late Phase Clinical Trials.
P2860
Q26745428-FFE6167C-DCE2-4FC3-9A63-E23961F6A70DQ26745838-BD1C09F3-E8C6-412E-A169-294C6152B9E4Q26777394-364DF73A-25C0-4FD5-B4E9-7A288C3EBACDQ26782845-C11E4965-056A-4C32-A850-A256E2CB3324Q26782902-F3579B4B-6671-4F22-A848-7C2224B4671AQ26795540-C0665CE8-90B8-4F1B-B641-31F4C0177897Q26799602-9469C684-15BE-4CEF-8FA7-04254960ABE5Q26801365-DAD8B684-4A5E-48A3-A55B-350A5D994001Q26822376-C7D55EC8-559C-44C7-B7DF-3BF04BA554FBQ26822550-4F47424A-C3BB-426D-9C5F-2855C1F8F173Q26853345-D3244C9F-9A15-48C5-A0CD-F1B2878188CCQ26861623-E793A3E3-57A1-49FB-892F-EF99253E084EQ26866013-3069B9E2-6744-4378-939F-0C216C4F28ECQ27028006-1D7E436A-120B-4287-A451-BC4ED1F174C9Q27030863-B781B500-5314-4453-AE9C-6DED3FE184AAQ27313856-32BF2ED0-5C8E-47E7-9B5E-6D31A9D55D78Q27324235-39D63DD6-7DAD-4F02-BD06-065A6C31BB59Q28079823-91106A77-28C6-4D42-A208-A777ABA17086Q28085769-C24AB8A1-3CBE-44DA-AB49-934555A2CFA9Q28271836-EFD75B27-83AD-4BD0-880C-4B459467FB19Q29393780-0898998B-37B8-457E-B309-64DF1D9C463FQ33410603-CDADF4DA-77E5-4715-A641-A165183B042FQ33456742-755E9588-4BBB-408D-87E1-F9C684F069A8Q33573863-A18C9F5C-3E7F-4C4F-9DC2-9CA6B935F93BQ33633262-90FEB371-CA2D-4E6A-86F1-7C2D81E7525DQ33766995-7F2BC420-D408-4435-9D62-FBC3143B8988Q33820695-22BA756A-EA2D-4D91-A07B-93E1FF3922C8Q34273968-0F11FA65-7DD8-4CEC-B704-B2D10456B430Q34363238-E9E605AC-1D2B-4F2A-95A3-B63B35C8C1E2Q35068768-B4C792F4-4592-4339-8D25-9E059BDE6DDBQ35083003-F0424555-6A0D-4963-BD91-708CA40EAEDCQ35104509-C534D87B-44BA-459A-8887-54F38B5646E4Q35296850-AD5848A2-8DAF-4E02-96B5-C74E1FE55652Q35477534-8D2FF395-94F3-4A41-A643-02A7ACA61D4AQ35591430-4C05475D-F51C-4360-87AC-C775BE79DC36Q35591760-646B1E04-BCB7-4D70-8BF7-6D01BF82207CQ35958223-EA0D33F1-60B5-4A31-B5DD-970995CFD746Q36142522-E17171BE-E8F0-4CBE-905A-23DC1BEC3C64Q36334405-647395B6-FFBB-4312-9B27-5092790E0285Q36438304-D131B2B1-C18F-490D-AA6B-ABC5212C2C07
P2860
Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Adoptive immunotherapy with un ...... topoietic cell transplantation
@ast
Adoptive immunotherapy with un ...... topoietic cell transplantation
@en
type
label
Adoptive immunotherapy with un ...... topoietic cell transplantation
@ast
Adoptive immunotherapy with un ...... topoietic cell transplantation
@en
prefLabel
Adoptive immunotherapy with un ...... topoietic cell transplantation
@ast
Adoptive immunotherapy with un ...... topoietic cell transplantation
@en
P2093
P2860
P50
P1433
P1476
Adoptive immunotherapy with un ...... topoietic cell transplantation
@en
P2093
Andromachi Scaradavou
Ann Jakubowski
Banu Oflaz-Sozmen
Diane George
Ekaterina Doubrovina
Esperanza B Papadopoulos
Farid Boulad
Glenn Heller
Guenther Koehne
Hugo Castro-Malaspina
P2860
P304
P356
10.1182/BLOOD-2011-08-371971
P407
P577
2011-12-02T00:00:00Z